Fundz

CurifyLabs raises €12M in Series A funding to enhance US operations and develop personalised medicine technology.

PRIVATEJul 06, 2026

Amount Raised

€12 Million

Round Type

Series A

FinlandManufacturingBiotechnologyArtificial IntelligencePharmaceuticalpharmaceuticals

Investors

HealthcapTesiLifeline VenturesSandwater

Description

CurifyLabs has secured €12 million in a Series A funding round to expand its operations in the United States. The funding will support the development of its personalised medicine platform and improve customer support. Co-led by Sandwater and HealthCap, the round also saw participation from Tesi and Lifeline Ventures. The funds will be utilized for strengthening the supply chain and accelerating product development.

Quick answer

CurifyLabs raised €12 Million in a Series A round, dated July 6, 2026. Investors: Healthcap, Tesi, Lifeline Ventures and Sandwater. CurifyLabs is based in Finland.

How much did CurifyLabs raise?
CurifyLabs raised €12 Million in a Series A round on July 6, 2026.
Who invested in CurifyLabs?
Healthcap, Tesi, Lifeline Ventures and Sandwater are named as investors in this round.
What does CurifyLabs do?
CurifyLabs is a Finnish healthtech company focused on modernizing and automating the manufacturing of compounded medications.
Where is CurifyLabs based and how big is it?
CurifyLabs is based in Finland. Fundz records about 29 employees.
Who are the decision-makers at CurifyLabs?
Fundz holds 3 contacts at CurifyLabs, including the Chief Commercial Officer (CCO). Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and pharmaceuticals around the same time

Companies in the same sectors as CurifyLabs that raised within 45 days of this round, from Fundz verified event records.

  • Phil Rivers Technology raised $30M (Series A) on August 13, 2026.
  • EagleSight Dynamic raised an undisclosed amount (Series A) on August 7, 2026.
  • Tarsus Pharmaceuticals raised $125M (Post-IPO Equity) on August 6, 2026.
  • China Pharma Holdings raised $5M (Post-IPO Equity) on July 23, 2026.
  • GMP Manufacturing Ltd raised $667K (Debt Financing) on July 8, 2026.
  • Katalyze AI raised $11M (Seed) on July 6, 2026.

Who to call at CurifyLabs, and when

A new round usually means CurifyLabs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CurifyLabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CurifyLabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CurifyLabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CurifyLabs

Location

Finland

About

CurifyLabs is a Finnish healthtech company focused on modernizing and automating the manufacturing of compounded medications. Their technology aims to improve the safety and suitability of medications for individual patient needs, particularly in vulnerable populations. Through innovative solutions like the Pharma Printer and cloud-based formulation library, CurifyLabs enhances the compounding process, making it faster and more reliable. The initiative also includes plans for an AI-driven platform to address supply chain challenges in pharmaceuticals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CurifyLabs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsSandra S., Chief Commercial Officer (CCO) hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CurifyLabs's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

CurifyLabs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.